{"content":"<li class=\"n-box-item date-title\" data-end=\"1443067199\" data-start=\"1442980800\" data-txt=\"Sunday, December 22, 2019\">Wednesday, September 23, 2015</li><li class=\"n-box-item sa-box-item\" data-id=\"2794176\" data-ts=\"1443045560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPLX\" target=\"_blank\">MPLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2794176-mplxs-marathon-pipe-line-unit-to-raise-patoka-tank-farm-shell-capacity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MPLX&#39;s Marathon Pipe Line unit to raise Patoka tank farm shell capacity</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/MPLX' title='MPLX LP'>MPLX</a> <font color='green'>+4.8%</font>&nbsp;AH following the disclosure that its Marathon Pipe Line unit has amended its existing Patoka, Ill., tank farm storage services agreement with Marathon Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corp.'>MPC</a>) to <a href=\"https://www.sec.gov/Archives/edgar/data/1552000/000155200015000054/mplxform8-kxfirstamendment.htm\" target=\"_blank\">increase available  shell capacity</a> to 2.626M barrels from 1.386M barrels due to the addition of four new tanks at the facility.</li>     <li>Under the agreement, MPC pays a monthly fee to store  crude oil at the Patoka tank farm, regardless of whether all contractual capacity is fully utilized.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2794176\" data-linked=\"MPLX&#39;s Marathon Pipe Line unit to raise Patoka tank farm shell capacity\" data-tweet=\"$MPLX $MPLX $MPC - MPLX&#39;s Marathon Pipe Line unit to raise Patoka tank farm shell capacity https://seekingalpha.com/news/2794176-mplxs-marathon-pipe-line-unit-to-raise-patoka-tank-farm-shell-capacity?source=tweet\" data-url=\"https://seekingalpha.com/news/2794176-mplxs-marathon-pipe-line-unit-to-raise-patoka-tank-farm-shell-capacity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2794156\" data-ts=\"1443044411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2794156-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4>&nbsp; <ul><li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+39.0%</font>. <a href='https://seekingalpha.com/symbol/BTE' title='Baytex Energy Corp.'>BTE</a> <font color='green'>+14.0%</font>. <a href='https://seekingalpha.com/symbol/SXC' title='SunCoke Energy'>SXC</a> <font color='green'>+12.0%</font>. <a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a> <font color='green'>+11.0%</font>. <a href='https://seekingalpha.com/symbol/CNX' title='CNX Resources Corporation'>CNX</a> <font color='green'>+9.0%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/RNWK' title='RealNetworks, Inc.'>RNWK</a> <font color='red'>-7.0%</font>. <a href='https://seekingalpha.com/symbol/FUL' title='H.B. Fuller Company'>FUL</a> <font color='red'>-6.0%</font>. <a href='https://seekingalpha.com/symbol/EXTR' title='Extreme Networks, Inc.'>EXTR</a> <font color='red'>-5.9%</font>. <a href='https://seekingalpha.com/symbol/CCXI' title='ChemoCentryx'>CCXI</a> <font color='red'>-4.9%</font>. ONTY <font color='red'>-4.7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"2794156\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$CNAT $BTE $SXC - After Hours Gainers / Losers https://seekingalpha.com/news/2794156-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2794156-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2794106\" data-ts=\"1443042267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFOYY\" target=\"_blank\">MFOYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2794106-russian-firms-set-up-for-wireless-spectrum-auction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Russian firms set up for wireless spectrum auction</a></h4><ul>   <li>Russia is set to auction 1800-MHz wireless airwaves next week, and has processed applications for the country's <a href=\"http://www.totaltele.com/view.aspx?ID=491226\" target=\"_blank\">four main mobile operators</a> to participate.</li>    <li>Mobile TeleSystems (<a href=\"https://seekingalpha.com/symbol/MBT\" title=\"Mobile TeleSystems\">MBT</a> <font color=\"red\">-2.1%</font>), VimpelCom (<a href=\"https://seekingalpha.com/symbol/VIP\" target=\"_blank\">VIP</a> <font color=\"red\">-1.5%</font>), Megafon (<a href=\"https://seekingalpha.com/symbol/MFOYY\" title=\"MegaFon OJSC\">OTC:MFOYY</a>) and Tele2 (<a href=\"https://seekingalpha.com/symbol/TLTZY\" title=\"Tele2 AB ADR\">OTCPK:TLTZY</a>) are certified to take part in the electronic auction. Russia is selling spectrum in nine regions.</li>    <li>While the band was previously set aside for voice communication, there are no restrictions on usage of airwaves won in the auction, and the country's Roscomnadzor regulator expects winners will put LTE to work in the band.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2794106\" data-linked=\"Russian firms set up for wireless spectrum auction\" data-tweet=\"$MFOYY $MFOYY $TLTZY - Russian firms set up for wireless spectrum auction https://seekingalpha.com/news/2794106-russian-firms-set-up-for-wireless-spectrum-auction?source=tweet\" data-url=\"https://seekingalpha.com/news/2794106-russian-firms-set-up-for-wireless-spectrum-auction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2794036\" data-ts=\"1443040397\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNAT\" target=\"_blank\">CNAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2794036-conatus-emricasan-shows-positive-results-in-mid-stage-study-in-portal-hypertension-falls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conatus&#39; emricasan shows positive results in mid-stage study in portal hypertension but falls short of complete efficacy in one endpoint</a></h4><ul>\n<li>Top-line results from a 23-subject <a href=\"https://clinicaltrials.gov/ct2/show/NCT02230683?term=emricasan&amp;rank=2\" target=\"_blank\">Phase 2 clinical trial</a> assessing Conatus Pharmaceuticals' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CNAT\" title=\"Conatus Pharmaceuticals\">CNAT</a>) lead product candidate emricasan for the treatment of portal hypertension in patients with liver cirrhosis successfully demonstrated efficacy as determined by two outcome measures.</li>\n<li>The two endpoints were: the change from baseline in hepatic venous pressure gradient (HVPG), a measure of pressure in the portal vein, and the change from baseline in cleaved Cytokeratin 18 (cCK18), a biomarker of excessive liver cell apoptosis (cell death), at Day 28. The results for cCK18 were statistically significant.</li>\n<li>The HVPG endpoint was analyzed in two groups: patients with values &gt;12 mmHg and those with values &lt;12 mmHg. The results for the higher baseline group were statistically significant (p&lt;0.003) but not for the lower baseline group (p=0.12) or the total evaluable (n=22) population (p=0.26).</li>\n<li>\n<a href=\"http://www.conatuspharma.com/emricasan/mechanism-of-action.htm\" target=\"_blank\">Emricasan </a>inhibits a family of enzymes that modulate essential cellular functions called <a href=\"https://en.wikipedia.org/wiki/Caspase\" target=\"_blank\">caspases</a>. The functions include those involved in apoptosis and inflammation. Capases 3 and 7 are major players in apoptosis. These enzymes cleave a key protein called <a href=\"https://biocare.net/wp-content/uploads/3061.pdf\" target=\"_blank\">CK18</a> (cytokeratin-18), part of which is the small fragment cCK18, which correlates to the magnitude of hepatocyte apoptosis. Emricasan inhibits apoptosis regardless of the stimuli that causes it.</li>\n<li>The company will host a conference call tomorrow morning at 8:30 am ET to discuss the data.</li>\n<li>Shares are up <font color=\"green\">31%</font> after hours on robust volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2794036\" data-linked=\"Conatus&#39; emricasan shows positive results in mid-stage study in portal hypertension but falls short of complete efficacy in one endpoint\" data-tweet=\"$CNAT - Conatus&#39; emricasan shows positive results in mid-stage study in portal hypertension but falls short of complete efficacy in one endpoint https://seekingalpha.com/news/2794036-conatus-emricasan-shows-positive-results-in-mid-stage-study-in-portal-hypertension-falls?source=tweet\" data-url=\"https://seekingalpha.com/news/2794036-conatus-emricasan-shows-positive-results-in-mid-stage-study-in-portal-hypertension-falls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793986\" data-ts=\"1443039370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793986-nokia-up-2-after-gaining-frances-approval-of-alcatel-lucent-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia up 2% after gaining France&#39;s approval of Alcatel-Lucent deal</a></h4><ul>   <li>Nokia (NYSE:<a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a>) finished <font color=\"green\">up 2%</font> in U.S. trading after <a href=\"http://www.fiercewireless.com/europe/story/nokia-ceo-gains-french-government-approval-alcatel-lucent-deal-rd-commitmen/2015-09-23\" target=\"_blank\">gaining French approval</a> for its \u20ac15.6B merger with Alcatel-Lucent (<a href=\"https://seekingalpha.com/symbol/ALU\" target=\"_blank\">ALU</a> <font color=\"green\">+2%</font>), an OK it secured by <a href=\"http://company.nokia.com/en/news/press-releases/2015/09/22/nokia-and-the-french-government-announce-agreement-on-a-shared-vision-of-innovation-in-france-enabled-by-nokias-proposed-combination-with-alcatel-lucent\" target=\"_blank\">committing to R&amp;D work</a> in France.</li>    <li>The company will use Alcatel-Lucent's French facilities to work on technologies including 5G and small cells, cyber-security and privacy, and optical transmission, among others. It will also establish a long-term investment fund of about \u20ac100M for research.</li>    <li>Progress with approvals is \"remarkable,\" Nokia CEO Rajeev Suri said, and months ahead of a planned 2016 closing. The key remaining approval is to come from China; Nokia moved to smooth that road by <a href=\"https://seekingalpha.com/news/2751356-nokia-paves-way-for-merger-approval-with-china-huaxin-jv\" target=\"_blank\">creating a joint venture</a> with China Huaxin.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2793986\" data-linked=\"Nokia up 2% after gaining France&#39;s approval of Alcatel-Lucent deal\" data-tweet=\"$NOK - Nokia up 2% after gaining France&#39;s approval of Alcatel-Lucent deal https://seekingalpha.com/news/2793986-nokia-up-2-after-gaining-frances-approval-of-alcatel-lucent-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/2793986-nokia-up-2-after-gaining-frances-approval-of-alcatel-lucent-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793916\" data-ts=\"1443037148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGA\" target=\"_blank\">MGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793916-magna-international-downgraded-cibc-on-volkswagen-exposure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Magna International downgraded at CIBC on Volkswagen exposure</a></h4><ul>     <li>Auto parts supplier Magna International (<a href=\"https://seekingalpha.com/symbol/MGA\" title=\"Magna International Inc.\">MGA</a> <font color=\"red\">-1.8%</font>) is <a href=\"http://business.financialpost.com/investing/trading-desk/magna-international-inc-downgraded-on-volkswagen-exposure\" target=\"_blank\">downgraded</a> to Sector Perform from Sector Outperform with a $52 price target, cut from $62.50, at CIBC in the wake of the Volkswagen emissions scandal.</li>     <li>CIBC notes that while MGA does not make diesel engines, it does make parts used in some Volkswagen vehicles and any slowdown in the carmaker\u2019s sales could slow earnings growth for MGA.</li>     <li>MGA took 11% of its 2014 revenue from VW, which is MGA's sixth-biggest customer, but MGA's diversified customer base may allow the company to <a href=\"http://www.bloomberg.com/news/articles/2015-09-22/vw-supplier-magna-falls-most-in-four-weeks-on-emissions-scandal\" target=\"_blank\">make up any shortfall</a> from a slowdown in volumes at VW, Canaccord analyst David Tyerman says.</li>\n<li>Shares have shed nearly 7% in the last two trading sessions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2793916\" data-linked=\"Magna International downgraded at CIBC on Volkswagen exposure\" data-tweet=\"$MGA - Magna International downgraded at CIBC on Volkswagen exposure https://seekingalpha.com/news/2793916-magna-international-downgraded-cibc-on-volkswagen-exposure?source=tweet\" data-url=\"https://seekingalpha.com/news/2793916-magna-international-downgraded-cibc-on-volkswagen-exposure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793906\" data-ts=\"1443035712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMB\" target=\"_blank\">WMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793906-reuters-williams-cos-to-discuss-revised-energy-transfer-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Williams Cos. to discuss revised Energy Transfer offer</a></h4><ul>     <li>Williams Cos. (<a href=\"https://seekingalpha.com/symbol/WMB\" title=\"Williams Companies Inc\">WMB</a> <font color=\"red\">-3.8%</font>) board is preparing to meet as soon as this week to consider a sale to Energy Transfer Equity (ETE <font color=\"red\">-3.7%</font>) in response to a <a href=\"http://www.reuters.com/article/2015/09/23/us-williamscompanies-m-a-energytransfer-idUSKCN0RN26X20150923\" target=\"_blank\">revised offer</a>, Reuters reports.</li>     <li>ETE has offered to tweak its all-stock offer for WMB, which is currently worth ~$34B, and pay for ~15% of the deal with cash, according to the report.</li>     <li>The bid was worth ~$48B in June when WMB rejected an acquisition proposal from ETE, and share prices have since dropped along with oil prices.</li>     <li>Also: <a href=\"https://seekingalpha.com/symbol/WPZ\" title=\"Williams Partners L.P.\">WPZ</a> <font color=\"red\">-4.4%</font>, ETP <font color=\"red\">-2.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2793906\" data-linked=\"Reuters: Williams Cos. to discuss revised Energy Transfer offer\" data-tweet=\"$WMB $WMB $ET - Reuters: Williams Cos. to discuss revised Energy Transfer offer https://seekingalpha.com/news/2793906-reuters-williams-cos-to-discuss-revised-energy-transfer-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/2793906-reuters-williams-cos-to-discuss-revised-energy-transfer-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>92&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793886\" data-ts=\"1443034623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMO\" target=\"_blank\">IMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793886-imperial-oil-cuts-spending-on-existing-projects-costs-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Imperial Oil cuts spending on existing projects as costs drop</a></h4><ul>     <li>Imperial Oil (<a href=\"https://seekingalpha.com/symbol/IMO\" title=\"Imperial Oil Ltd\">IMO</a> <font color=\"red\">-2.6%</font>) has been able to <a href=\"http://www.bloomberg.com/news/articles/2015-09-23/imperial-oil-cuts-spending-on-existing-projects-as-costs-drop\" target=\"_blank\">lower the amount of capital reinvestment</a> needed to sustain the business to ~C$1.2/year from C$2B a year ago, helped by shrinking supplier costs, CEO Rich Kruger says at the company\u2019s annual investor day.</li>\n<li>Kruger sees IMO's overall annual spending on expansion and maintenance to average ~C$2.5B ($1.9B) in the coming years as it cuts costs and  slows expansion.</li>     <li>Canadian oil sands producers have cut budgets this year; IMO operates bitumen mining at its Kearl  site, where it is aiming to reduce cash operating costs of less than C$30/bbl, in addition to its Cold Lake and Nabiye facilities as well as  owning a stake in Syncrude.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2793886\" data-linked=\"Imperial Oil cuts spending on existing projects as costs drop\" data-tweet=\"$IMO - Imperial Oil cuts spending on existing projects as costs drop https://seekingalpha.com/news/2793886-imperial-oil-cuts-spending-on-existing-projects-costs-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/2793886-imperial-oil-cuts-spending-on-existing-projects-costs-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793866\" data-ts=\"1443032883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMLP\" target=\"_blank\">SMLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793866-summit-midstream-plunges-energy-capital-seeks-buyers-for-smlp-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Summit Midstream plunges as Energy Capital seeks buyers for SMLP stake</a></h4><ul>     <li>Energy Capital Partners is <a href=\"http://www.bloomberg.com/news/articles/2015-09-23/energy-capital-said-to-seek-buyers-for-stake-in-summit-midstream\" target=\"_blank\">seeking buyers</a> for its interest in Summit Midstream Partners (<a href='https://seekingalpha.com/symbol/SMLP' title='Summit Midstream Partners'>SMLP</a> <font color='red'>-4.2%</font>), a deal that would include a minority stake in the pipeline operator as well as ownership of its general partner, Bloomberg reports.</li><li>The P-E firm reportedly is working with Barclays to find a buyer for the assets, which could fetch at least $2B.</li><li>Energy Capital indirectly  owns ~44% limited partnership interest in SMLP.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"2793866\" data-linked=\"Summit Midstream plunges as Energy Capital seeks buyers for SMLP stake\" data-tweet=\"$SMLP - Summit Midstream plunges as Energy Capital seeks buyers for SMLP stake https://seekingalpha.com/news/2793866-summit-midstream-plunges-energy-capital-seeks-buyers-for-smlp-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/2793866-summit-midstream-plunges-energy-capital-seeks-buyers-for-smlp-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793806\" data-ts=\"1443029604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQIX\" target=\"_blank\">EQIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793806-equinix-deals-sunedison-to-run-california-centers-on-renewable-energy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Equinix deals with SunEdison to run California centers on renewable energy</a></h4><ul>   <li>Data-center operator Equinix (<a href=\"https://seekingalpha.com/symbol/EQIX\" title=\"Equinix, Inc.\">EQIX</a> <font color=\"red\">-0.3%</font>) has gone 100% renewable-energy with its California operations, signing a deal with SunEdison (<a href=\"https://seekingalpha.com/symbol/SUNE\" target=\"_blank\">SUNE</a> <font color=\"red\">-5.5%</font>) to supply 105 megawatts of new solar power for its in-state data centers.</li>    <li>The deal will let Equinix operate 11 data centers and its headquarters entirely on renewable energy, and boost its renewables footprint globally to 43% from 30%. The company says it's responding to Internet customers who are demanding renewable sources.</li>    <li>A new project will be located just north of the U.S.-Mexico border, near Calexico, and produce 150 megawatts for the California system.</li>    <li>The deal is part of Equinix's Earth Day goal of the company going 100% renewable.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2793806\" data-linked=\"Equinix deals with SunEdison to run California centers on renewable energy\" data-tweet=\"$EQIX $EQIX $SUNEQ - Equinix deals with SunEdison to run California centers on renewable energy https://seekingalpha.com/news/2793806-equinix-deals-sunedison-to-run-california-centers-on-renewable-energy?source=tweet\" data-url=\"https://seekingalpha.com/news/2793806-equinix-deals-sunedison-to-run-california-centers-on-renewable-energy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793776\" data-ts=\"1443027473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793776-bhps-proposed-dividend-policy-may-cost-australian-shareholders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BHP&#39;s proposed dividend policy may cost Australian shareholders</a></h4><ul>     <li>BHP Billiton (<a href=\"https://seekingalpha.com/symbol/BHP\" title=\"BHP Billiton Limited\">BHP</a> <font color=\"red\">-1.6%</font>) reveals a plan to <a href=\"http://www.reuters.com/article/2015/09/23/bhp-dividends-idUSL4N11T03X20150923\" target=\"_blank\">alter its dividend funding policy</a> to ensure a promise on payouts to its British shareholders, but the move could come at a cost to its Australian shareholders.</li>     <li>Under the proposal, BHP's Australian company would effectively make payments to the British company to enable dividends to be paid, but the payment would mean BHP's Australian shareholders lose out on getting tax benefits, or franking credits, on the amount.</li>     <li>BHP says it does not expect any impact on its ability to pay fully-franked dividends in future, given the $25.4B franking credits available on its books.</li>     <li>The British and Australian sets of shareholders will vote on the proposal in October and November, respectively.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2793776\" data-linked=\"BHP&#39;s proposed dividend policy may cost Australian shareholders\" data-tweet=\"$BHP - BHP&#39;s proposed dividend policy may cost Australian shareholders https://seekingalpha.com/news/2793776-bhps-proposed-dividend-policy-may-cost-australian-shareholders?source=tweet\" data-url=\"https://seekingalpha.com/news/2793776-bhps-proposed-dividend-policy-may-cost-australian-shareholders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793726\" data-ts=\"1443026410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793726-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> ABGB <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CNCE' title='Concert Pharmaceuticals, Inc.'>CNCE</a> <font color='green'>+18%</font>. CVSL <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/EVOK' title='Evoke Pharma, Inc.'>EVOK</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/BMR' title='BioMed Realty Trust, Inc.'>BMR</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/FNFG' title='First Niagara Financial Group Inc.'>FNFG</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> OGXI <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/HNSN' title='Hansen Medical, Inc.'>HNSN</a>&nbsp;<font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderurgica Nacional'>SID</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/EFOI' title='Energy Focus, Inc.'>EFOI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/QUMU' title='Qumu Corporation'>QUMU</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ACI' title='Albertsons Companies Inc'>ACI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AXPW' title='Axion Power International, Inc.'>OTC:AXPW</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AGRX' title='Agile Therapeutics, Inc.'>AGRX</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2793726\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ABGOF $HRTX $CNCE - Midday Gainers / Losers https://seekingalpha.com/news/2793726-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2793726-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793716\" data-ts=\"1443026306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793716-u-s-steel-union-contract-talks-to-resume-sunday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel, union contract talks to resume Sunday</a></h4><ul>     <li>U.S. Steel (<a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"red\">-3%</font>) and the United Steelworkers will <a href=\"http://www.bizjournals.com/pittsburgh/news/2015/09/23/u-s-steel-usw-contract-talks-to-resume-sunday.html\" target=\"_blank\">resume contract talks</a> on Sept. 27, according to an update from the union.</li>\n<li>The union says U.S. Steel has proposed dramatic benefit cuts and employee health care premiums for active employees.</li>     <li>The negotiations cover more than 16,500 employees in production, maintenance, office and technical and  plant protection units from 24 local unions across the U.S.</li>\n<li>The previous labor agreement expired Sept. 1, but the union has continued to work at U.S. Steel facilities.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2793716\" data-linked=\"U.S. Steel, union contract talks to resume Sunday\" data-tweet=\"$X - U.S. Steel, union contract talks to resume Sunday https://seekingalpha.com/news/2793716-u-s-steel-union-contract-talks-to-resume-sunday?source=tweet\" data-url=\"https://seekingalpha.com/news/2793716-u-s-steel-union-contract-talks-to-resume-sunday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793686\" data-ts=\"1443024773\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNCE\" target=\"_blank\">CNCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793686-concert-pharmas-ctpminus-656-shows-superior-pharmacokinetic-profile-vs-vertexs-kalydeco\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Concert Pharma&#39;s CTP-656 shows superior pharmacokinetic profile vs Vertex&#39;s Kalydeco; shares up 18%</a></h4><ul>\n<li>Thinly traded micro cap Concert Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/CNCE\" title=\"Concert Pharmaceuticals, Inc.\">CNCE</a> <font color=\"green\">+17.5%</font>) is up nicely on double normal volume, albeit on turnover of only 530K shares. Yesterday, the company announced that its investigational CTP-656, a deuterium-modified version of ivacaftor, demonstrated a superior pharmacokinetic profile compared to Vertex Pharmaceuticals' (<a href=\"https://seekingalpha.com/symbol/VRTX\" title=\"Vertex Pharmaceuticals Incorporated\">VRTX</a> <font color=\"red\">-1.7%</font>) <a href=\"http://www.kalydeco.com/\" target=\"_blank\">Kalydeco </a>(ivacaftor) in a Phase 1 study. The results were presented at the Cystic Fibrosis Trusts UK Conference in Manchester, England.</li>\n<li>In data generated from ten healthy volunteers, <a href=\"http://www.concertpharma.com/product-pipeline/\" target=\"_blank\">CTP-656</a> showed a reduced rate of clearance, longer half-life, substantially increased exposure and greater plasma levels at 24 hours versus Kalydeco.</li>\n<li>A Phase 1 study to assess ascending doses of CTP-656 in healthy volunteers should commence in Q4. A Phase 2 trial is planned of 2016.</li>\n<li>\n<a href=\"http://www.concertpharma.com/technology-overview/\" target=\"_blank\">Deuterium</a>, or heavy hydrogen, forms a more stable bond with carbon compared to regular hydrogen. This potentially increases the stability of drugs since their metabolism often involves the breaking of hydrogen-carbon bonds.</li>\n<li>Vertex generates almost all of its revenues (over 90%) from Kalydeco. Its most recent guidance projects sales of $575M - 590M in 2015.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2793686\" data-linked=\"Concert Pharma&#39;s CTP-656 shows superior pharmacokinetic profile vs Vertex&#39;s Kalydeco; shares up 18%\" data-tweet=\"$CNCE $CNCE $VRTX - Concert Pharma&#39;s CTP-656 shows superior pharmacokinetic profile vs Vertex&#39;s Kalydeco; shares up 18% https://seekingalpha.com/news/2793686-concert-pharmas-ctpminus-656-shows-superior-pharmacokinetic-profile-vs-vertexs-kalydeco?source=tweet\" data-url=\"https://seekingalpha.com/news/2793686-concert-pharmas-ctpminus-656-shows-superior-pharmacokinetic-profile-vs-vertexs-kalydeco\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793656\" data-ts=\"1443023395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793656-bhp-ceo-pay-cut-nearly-in-half-after-global-commodities-collapse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BHP CEO pay cut nearly in half after global commodities collapse</a></h4><ul>     <li>BHP Billiton (<a href=\"https://seekingalpha.com/symbol/BHP\" title=\"BHP Billiton Limited\">BHP</a> <font color=\"red\">-1.5%</font>) CEO Andrew Mackenzie saw his <a href=\"http://www.bloomberg.com/news/articles/2015-09-23/bhp-ceo-s-paycheck-slashed-after-global-commodities-collapse\" target=\"_blank\">total compensation fall 43%</a> in the past fiscal year to June 30, feeling the pain from sharply lower commodity prices that sent the stock ~20% lower and underlying profits cut by 52% during the period.</li>     <li>BHP says Mackenzie earned US$4.6M in cash and stock options, in addition to other benefits such as pension contributions, for the fiscal year, vs. the $8M pay package he received a year earlier, which was his first as the head of the company.</li>     <li>BHP also will cut pay to its chairman by 13% and reduce fees for non-executive directors in response to the weak outlook for commodities.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2793656\" data-linked=\"BHP CEO pay cut nearly in half after global commodities collapse\" data-tweet=\"$BHP - BHP CEO pay cut nearly in half after global commodities collapse https://seekingalpha.com/news/2793656-bhp-ceo-pay-cut-nearly-in-half-after-global-commodities-collapse?source=tweet\" data-url=\"https://seekingalpha.com/news/2793656-bhp-ceo-pay-cut-nearly-in-half-after-global-commodities-collapse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793536\" data-ts=\"1443019501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGEN\" target=\"_blank\">MGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793536-signal-genetics-up-14-on-news-of-deal-leading-biopharma-firm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Signal Genetics up 14% on news of deal with &quot;leading biopharma&quot; firm</a></h4><ul>\n<li>Thinly traded nano cap Signal Genetics (SGNL <font color=\"green\">+13.5%</font>) jumps on a whopping 43x surge in volume in response to its announcement of the signing of a Master Service Agreement (MSA) with an unnamed \"leading biopharmaceutical company.\" The first two projects under the MSA will deploy the company's proprietary MyPRS test to inform the clinical development program of a novel treatment, including potential combinations with current drugs, for multiple myeloma patients. The projects should commence before the end of the year.</li>\n<li>This is the second MSA Signal has closed in 2015.</li>\n<li>\n<a href=\"https://www.signalgenetics.com/myprsOverview.html\" target=\"_blank\">MyPRS </a>(Myeloma Prognostic Risk Signature) test is a microarray-based gene expression profiling assay used to assist with the management of patients with multiple myeloma and related disorders.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2793536\" data-linked=\"Signal Genetics up 14% on news of deal with &quot;leading biopharma&quot; firm\" data-tweet=\"$MGEN - Signal Genetics up 14% on news of deal with &quot;leading biopharma&quot; firm https://seekingalpha.com/news/2793536-signal-genetics-up-14-on-news-of-deal-leading-biopharma-firm?source=tweet\" data-url=\"https://seekingalpha.com/news/2793536-signal-genetics-up-14-on-news-of-deal-leading-biopharma-firm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793486\" data-ts=\"1443017735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPLA\" target=\"_blank\">LPLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793486-activist-investor-marcato-capital-discloses-6_3-stake-in-lpl-financial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activist investor Marcato Capital discloses 6.3% stake in LPL Financial</a></h4><ul>     <li>LPL Financial (<a href=\"https://seekingalpha.com/symbol/LPLA\" title=\"LPL Financial Holdings Inc.\">LPLA</a> <font color=\"green\">+1.9%</font>) adds to yesterday's gains following the <a href=\"https://www.sec.gov/Archives/edgar/data/1397911/000119312515325284/d21600dsc13d.htm\" target=\"_blank\">disclosure</a> that activist investor Marcato Capital Management <a href=\"http://www.wsj.com/articles/activist-investor-marcato-capital-discloses-6-3-stake-in-lpl-financial-1442944856\" target=\"_blank\">took a 6.3% stake</a> in the independent brokerage, saying the shares are undervalued.</li>     <li>Marcato said in the SEC filing that it may seek talks regarding LPL\u2019s business and strategies,  including reviewing various options such as improving its capital structure, mergers and acquisitions and general corporate strategies.</li>     <li>Marcato's ~6M shares makes it one of LPL's largest shareholders.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2793486\" data-linked=\"Activist investor Marcato Capital discloses 6.3% stake in LPL Financial\" data-tweet=\"$LPLA - Activist investor Marcato Capital discloses 6.3% stake in LPL Financial https://seekingalpha.com/news/2793486-activist-investor-marcato-capital-discloses-6_3-stake-in-lpl-financial?source=tweet\" data-url=\"https://seekingalpha.com/news/2793486-activist-investor-marcato-capital-discloses-6_3-stake-in-lpl-financial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793286\" data-ts=\"1443014111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABGOF\" target=\"_blank\">ABGOF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793286-reuters-abengoa-close-to-deal-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Abengoa close to deal on capital raise</a></h4><ul>     <li>Abengoa (ABGB) <font color=\"green\">+23%</font> premarket on news that it is <a href=\"http://www.reuters.com/article/2015/09/23/abengoa-equity-idUSE8N11T02T20150923\" target=\"_blank\">close to a deal with creditor banks</a> on its planned \u20ac650M ($725M) capital raise, following several weeks of negotiations.</li>     <li>Santander, HSBC and Credit Agricole have accepted backing the share issue and other lenders are expected to join the list, according to a Reuters report.</li>     <li>ABGB's main shareholder is said to haveaccepted an overhaul of the corporate structure and an issue of new shares at a lower price than it initially wanted.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2793286\" data-linked=\"Reuters: Abengoa close to deal on capital raise\" data-tweet=\"$ABGOF - Reuters: Abengoa close to deal on capital raise https://seekingalpha.com/news/2793286-reuters-abengoa-close-to-deal-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/2793286-reuters-abengoa-close-to-deal-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793266\" data-ts=\"1443013957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793266-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> SGNL <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CDTI' title='Clean Diesel Technologies, Inc.'>OTC:CDTI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BMR' title='BioMed Realty Trust, Inc.'>BMR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/FNFG' title='First Niagara Financial Group Inc.'>FNFG</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/OREX' title='Orexigen Therapeutics, Inc.'>OREX</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> OGXI <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/AXPW' title='Axion Power International, Inc.'>OTC:AXPW</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"2793266\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$MGEN $HRTX $CDTI - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/2793266-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/2793266-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793216\" data-ts=\"1443013132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTXS\" target=\"_blank\">CTXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793216-reuters-citrix-making-final-effort-to-sell-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Citrix making final effort to sell the company</a></h4><ul>     <li>Citrix Systems (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTXS\" title=\"Citrix Systems, Inc.\">CTXS</a>) <font color=\"green\">+2.6%</font> premarket following a Reuters report that the cloud computing company is <a href=\"http://www.reuters.com/article/2015/09/22/us-citrix-m-a-idUSKCN0RM2T920150922\" target=\"_blank\">making a final attempt to sell itself</a> as a whole before it embarks on asset sales.</li>     <li>CTXS, which had attracted the interest of P-E investors before it agreed in July to give Elliott Management a seat on its board, is said to have entered new conversations with buyout firms and Dell, which took itself private two years ago.</li>     <li>If CTXS does not sell itself in its entirety, it would not just seek to sell or spin off its GoTo products but also would explore options for other assets down the line, according to the report.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2793216\" data-linked=\"Reuters: Citrix making final effort to sell the company\" data-tweet=\"$CTXS - Reuters: Citrix making final effort to sell the company https://seekingalpha.com/news/2793216-reuters-citrix-making-final-effort-to-sell-company?source=tweet\" data-url=\"https://seekingalpha.com/news/2793216-reuters-citrix-making-final-effort-to-sell-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793166\" data-ts=\"1443010449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMR\" target=\"_blank\">BMR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793166-bloomberg-biomed-exploring-sale-interest-from-blackstone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: BioMed exploring sale, with interest from Blackstone</a></h4><ul>\n<li>BioMed Realty Trust (NYSE:<a href=\"https://seekingalpha.com/symbol/BMR\" title=\"BioMed Realty Trust, Inc.\">BMR</a>) <font color=\"green\">+8.9%</font> premarket following a Bloomberg report that the REIT is <a href=\"http://www.bloomberg.com/news/articles/2015-09-22/biomed-realty-said-exploring-sale-with-interest-from-blackstone\" target=\"_blank\">exploring a sale</a> and has drawn interest from  firms including Blackstone (NYSE:<a href=\"https://seekingalpha.com/symbol/BX\" title=\"The Blackstone Group L.P.\">BX</a>).</li>\n<li>The landlord with properties catering to biotech companies is said to be working with Morgan Stanley to consider options.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2793166\" data-linked=\"Bloomberg: BioMed exploring sale, with interest from Blackstone\" data-tweet=\"$BMR $BMR $BX - Bloomberg: BioMed exploring sale, with interest from Blackstone https://seekingalpha.com/news/2793166-bloomberg-biomed-exploring-sale-interest-from-blackstone?source=tweet\" data-url=\"https://seekingalpha.com/news/2793166-bloomberg-biomed-exploring-sale-interest-from-blackstone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2793106\" data-ts=\"1443009595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHV\" target=\"_blank\">ACHV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2793106-oncogenex-pharmas-apatorsen-flunks-mid-stage-study-in-pancreatic-cancer-shares-slump-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoGenex Pharma&#39;s apatorsen flunks mid-stage study in pancreatic cancer; shares slump 18% premarket</a></h4><ul>\n<li>OncoGenex Pharmaceuticals' (OGXI) experimental apatorsen (OGX-427), in combination with Celgene's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CELG\" title=\"Celgene Corporation\">CELG</a>) <a href=\"http://www.abraxane.com/\" target=\"_blank\">Abraxane </a>(paclitaxel) and gemcitabine, failed to show a treatment benefit compared to Abraxane and <a href=\"http://chemocare.com/chemotherapy/drug-info/gemcitabine.aspx\" target=\"_blank\">gemcitabine</a> alone in a Phase 2 clinical trial in treatment-naive metastatic pancreatic cancer patients. The results of the study, called Rainier, will be presented by sponsor Sarah Cannon Research Institute at a future medical conference.</li>\n<li>CEO Scott Cormack says, \"While we are disappointed with the Rainier results, we also recognize the challenges associated with developing effective treatments for such a lethal and complex disease. We remain confident in our broader apatorsen program, which includes ongoing Phase 2 clinical trials in lung, prostate and bladder cancers.\"</li>\n<li>\n<a href=\"http://oncogenex.com/apatorsen-ogx-427\" target=\"_blank\">Apatorsen </a>is a once-weekly intravenous drug designed to inhibit heat shock protein 27 (<a href=\"https://en.wikipedia.org/wiki/Hsp27\" target=\"_blank\">Hsp27</a>), an intracellular protein that helps cancer cells survive.</li>\n<li>There are ~340K new cases of pancreatic cancer each year worldwide. Most patients die within the first year of diagnosis. The five-year survival rate is less than 10%.</li>\n<li>Shares are off <font color=\"red\">18%</font> premarket on increased volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2793106\" data-linked=\"OncoGenex Pharma&#39;s apatorsen flunks mid-stage study in pancreatic cancer; shares slump 18% premarket\" data-tweet=\"$ACHV $ACHV $CELG - OncoGenex Pharma&#39;s apatorsen flunks mid-stage study in pancreatic cancer; shares slump 18% premarket https://seekingalpha.com/news/2793106-oncogenex-pharmas-apatorsen-flunks-mid-stage-study-in-pancreatic-cancer-shares-slump-18?source=tweet\" data-url=\"https://seekingalpha.com/news/2793106-oncogenex-pharmas-apatorsen-flunks-mid-stage-study-in-pancreatic-cancer-shares-slump-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":22,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}